For more information, see the documentation on MediaWiki's support of SVG images
It is approved by the FDA for chronic weight management in adults with obesity (BMI 30), or overweight (BMI 27) with at least one weight-related condition, such as type 2 diabetes, high blood pressure, or high cholesterol
GLP-1 is an incretin hormone naturally secreted by L-cells in the small intestine in response to food intake
In 2025, GLP-1 weight-loss drugs, a new class of medications, entered the Indian market
Tirzepatide is not suggested for individuals with a history of pancreatitis or thyroid cancer, as it may increase the risk of these conditions
But now, more often, we see but do not quite believe even some of the most romantic tales from the Olympics